Viewing Study NCT05290935


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-01-02 @ 4:41 PM
Study NCT ID: NCT05290935
Status: UNKNOWN
Last Update Posted: 2022-03-22
First Post: 2022-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial
Sponsor: Lei Li
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Cervical Carcinoma View
None Persistent Advanced Cervical Carcinoma View
None Chemotherapy View
None Immune Checkpoint Inhibitors View
None Anti-PD-1 Antibody View
None Albumin-bound Paclitaxel View
Keywords: